Frelii (FRLI) Osake Kurssi

Frelii Inc is primarily active in the biotechnology industry.

The main competitors of Frelii Inc in the market include companies like 23andMe, Ancestry.com, and MyHeritage.

Frelii Inc is a leading company in the field of personalized health and wellness solutions. Established in [year], Frelii has a rich history of innovation and breakthroughs in the healthcare industry. The company focuses on utilizing advanced genetic sequencing and AI technology to develop personalized treatment plans for individuals, revolutionizing the way healthcare is delivered. Frelii's commitment to research and development has led to numerous partnerships and collaborations with renowned institutions and experts in the field. The company's dedication to providing cutting-edge healthcare solutions has positioned Frelii Inc as a trusted name in the industry. With its extensive expertise and forward-thinking approach, Frelii continues to pave the way for a healthier future.

Frelii Inc, a leading company in the field of personalized health sciences, has achieved several significant milestones. The company successfully launched its revolutionary AI-powered genomic sequencing platform, empowering individuals with actionable health insights and personalized treatment options. Frelii Inc has also secured strategic partnerships with prominent healthcare organizations, enabling them to expand their reach and accelerate the adoption of their advanced genetic testing solutions. Furthermore, the company has received prestigious awards and recognition for its groundbreaking contributions to the healthcare industry. Frelii Inc continues to pioneer innovative advancements in personalized medicines, positively impacting the lives of countless individuals worldwide.

Frelii Inc is primarily present in the United States.

Frelii Inc represents a set of values and a corporate philosophy focused on the advancement of personalized medicine and genetic testing. With their cutting-edge technology and comprehensive DNA analysis, they strive to empower individuals to make informed healthcare decisions. Frelii Inc is committed to enhancing the health and well-being of their customers by providing accurate genetic insights and tailored solutions. They prioritize scientific rigor, data privacy, and ethical practices, ensuring the utmost care for their customers' genetic information. Frelii Inc aims to pioneer breakthroughs in personalized healthcare, revolutionizing the way we diagnose, prevent, and treat diseases.

Nykyisellä valuuttakurssilla Frelii-osake noteerataan hintaan 0,00 EUR (0,00 USD).

Frelii Inc. is an American company based in Utah that was founded in 2017. It is a leading company in the field of genome analysis and DNA testing, providing customized solutions for their customers' health needs. The company utilizes cutting-edge technology and expertise to develop DNA tests that are capable of providing disease-preventive and predictive information. Frelii Inc. offers three different divisions tailored to the needs of their customers. These divisions include Frelii Health, Frelii DNA, and Frelii Genomic Research. Each division focuses on a specific area of genome analysis to provide specialized solutions for their customers' needs. Frelii Health is the first division of the company, offering individuals and families personalized DNA tests for improved health conditions. Frelii Health focuses on improving the health and well-being of their customers by providing genetic information for personalized nutrition, personalized fitness programs, personalized lifestyle advice, and more. Frelii DNA is the second division of the company, focusing on analyzing an individual's DNA to understand their traits and behaviors. The division suggests personalized solutions for everyday use and is an important tool for customers who have health-related questions related to their DNA. Frelii DNA also provides a simple method for storing DNA samples so that they can be analyzed when needed. Frelii Genomic Research is the third division of the company, focusing on DNA research that helps the company leverage the latest developments and innovations in genomics to improve their genetic tests and solutions. Frelii Genomic Research also provides cloud-based platforms for scientists and researchers from around the world to access genetic information and collaborate on it. Frelii Inc. also offers a wide range of products that customers can choose to use. These products include DNA test kits that are delivered directly to the user's home to enable quick and easy analysis of DNA samples. Additionally, the company offers a range of personalized nutrition, fitness, and lifestyle solutions to enable their customers to lead better lives. Overall, Frelii Inc. provides their customers with personalized and tailored genetic solutions to achieve a better understanding of their DNA and genetic profiles. The company utilizes cutting-edge technology and research to develop genetic tests and solutions that lead to a healthier and more productive lifestyle. With its various divisions and products, Frelii Inc. is committed to customer-oriented and innovative solutions, leading the company into the future of genomics and DNA analysis.

Liikevaihtoa ei voida laskea Frelii:lle tällä hetkellä.

Voittoa ei voida laskea Frelii:lle tällä hetkellä.

P/E-suhdetta ei voida laskea Frelii:lle tällä hetkellä.

P/S-suhdetta ei voida laskea Frelii:lle tällä hetkellä.

Frelii:n Eulpool-laatuscore on 4/10.

Frelii:n ISIN on US3570511010. ISIN (International Securities Identification Number) on maailmanlaajuisesti ainutlaatuinen arvopaperin tunnus.

Frelii:n WKN on A2JF9P. WKN (Wertpapierkennnummer) on kuusinumeroinen saksalainen arvopaperin tunnus.

Frelii:n ticker on FRLI. Tämä pörssinoteeraus käytetään Frelii-osakkeiden kauppaan pörssissä.

Frelii maksoi osinkoa joka vuosi viimeisten 0 vuoden aikana.

Frelii kuuluu sektoriin 'Terveydenhuolto'.

Frelii:n osingot jaetaan valuutassa USD.